Immunotherapy and Irreversible Electroporation for Advanced Pancreatic Cancer
Phase 2
10
about 12 years
18+
1 site in KY
What this study is about
Researchers are testing whether irreversible electroporation, given together with Nivolumab, can help people with locally advanced pancreatic cancer. The trial will also look at how well this treatment works and if it causes any side effects.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nivolumab
- 2.Undergo Irreversible Electroporation
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
nivolumab (Immune checkpoint inhibitor; blocks PD-1 receptor on T cells)
infusion
Primary: Safety and Tolerability of Combination Irreversible Electroporation and Nivolumab Treatment
Secondary: Overall Survival, Progression Free Survival